Whang-Peng J - Search Results

1

Spider angiomas in patients with liver cirrhosis: role of vascular endothelial growth factor and basic fibroblast growth factor.

Li CP, Lee FY, Hwang SJ, Lu RH, Lee WP, Chao Y, Wang SS, Chang FY, Whang-Peng J, Lee SD. Li CP, et al. World J Gastroenterol. 2003 Dec;9(12):2832-5. doi: 10.3748/wjg.v9.i12.2832. World J Gastroenterol. 2003. PMID: 14669345 Free PMC article.

2

Phase II study of megestrol acetate in the treatment of hepatocellular carcinoma.

Chao Y, Chan WK, Wang SS, Lai KH, Chi CW, Lin CY, Chan A, Whang-Peng J, Lui WY, Lee SD. Chao Y, et al. J Gastroenterol Hepatol. 1997 Apr;12(4):277-81. doi: 10.1111/j.1440-1746.1997.tb00421.x. J Gastroenterol Hepatol. 1997. PMID: 9195366 Clinical Trial.

3

Clinical trials of HCC in Taiwan.

Whang-Peng J, Chao Y. Whang-Peng J, et al. Hepatogastroenterology. 1998 Nov-Dec;45(24):1937-43. Hepatogastroenterology. 1998. PMID: 9951844 Review.

4

Chemotherapy with etoposide, doxorubicin, cisplatin, 5-fluorouracil, and leucovorin for patients with advanced hepatocellular carcinoma.

Yuan JN, Chao Y, Lee WP, Li CP, Lee RC, Chang FY, Yen SH, Lee SD, Whang-Peng J. Yuan JN, et al. Med Oncol. 2008;25(2):201-6. doi: 10.1007/s12032-007-9013-3. Epub 2007 Oct 6. Med Oncol. 2008. PMID: 18488159 Clinical Trial.

5

Phase II and pharmacokinetic study of paclitaxel therapy for unresectable hepatocellular carcinoma patients.

Chao Y, Chan WK, Birkhofer MJ, Hu OY, Wang SS, Huang YS, Liu M, Whang-Peng J, Chi KH, Lui WY, Lee SD. Chao Y, et al. Br J Cancer. 1998 Jul;78(1):34-9. doi: 10.1038/bjc.1998.438. Br J Cancer. 1998. PMID: 9662247 Free PMC article. Clinical Trial.

6

Phase II study of flutamide in the treatment of hepatocellular carcinoma.

Chao Y, Chan WK, Huang YS, Teng HC, Wang SS, Lui WY, Whang-Peng J, Lee SD. Chao Y, et al. Cancer. 1996 Feb 15;77(4):635-9. Cancer. 1996. PMID: 8616754 Clinical Trial.

7

A G-quadruplex ligand 3,3'-diethyloxadicarbocyanine iodide induces mitochondrion-mediated apoptosis but not decrease of telomerase activity in nasopharyngeal carcinoma NPC-TW01 cells.

Li CP, Huang JH, Chang AC, Hung YM, Lin CH, Chao Y, Lee SD, Whang-Peng J, Huang TS. Li CP, et al. Pharm Res. 2004 Jan;21(1):93-100. doi: 10.1023/b:pham.0000012166.44521.1f. Pharm Res. 2004. PMID: 14984262

8

Phase I-II trial of weekly gemcitabine plus high-dose 5-fluorouracil and leucovorin in advanced pancreatic cancer.

Shiah HS, Cheng AL, Hsu C, Hsu CH, Liu TW, Chang JY, Jan CM, Chao Y, Yu WL, Chuang TR, Whang-Peng J, Chen LT. Shiah HS, et al. J Gastroenterol Hepatol. 2006 Mar;21(3):531-6. doi: 10.1111/j.1440-1746.2005.03957.x. J Gastroenterol Hepatol. 2006. PMID: 16638094 Clinical Trial.

9

alpha-fetoprotein response predicts survival benefits of thalidomide in advanced hepatocellular carcinoma.

Chen LT, Liu TW, Chao Y, Shiah HS, Chang JY, Juang SH, Chen SC, Chuang TR, Chin YH, Whang-Peng J. Chen LT, et al. Aliment Pharmacol Ther. 2005 Aug 1;22(3):217-26. doi: 10.1111/j.1365-2036.2005.02547.x. Aliment Pharmacol Ther. 2005. PMID: 16091059 Free article.

10

Phase I and pharmacokinetic study of oral thalidomide in patients with advanced hepatocellular carcinoma.

Shiah HS, Chao Y, Chen LT, Yao TJ, Huang JD, Chang JY, Chen PJ, Chuang TR, Chin YH, Whang-Peng J, Liu TW. Shiah HS, et al. Cancer Chemother Pharmacol. 2006 Nov;58(5):654-64. doi: 10.1007/s00280-006-0203-z. Epub 2006 Mar 7. Cancer Chemother Pharmacol. 2006. PMID: 16520988 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

387 results

Search Page

Filters